Veritas Aortic Solutions Raises $12M Seed Funding
2026-06-01
Tweet
COSTA MESA, CA, Veritas Aortic Solutions, the latest company to spin out of inQB8 Medical Technologies, is pleased to announce the closing of $12M in Seed financing.
Veritas Aortic Solutions, the latest company to spin out of inQB8 Medical Technologies, is pleased to announce the closing of $12M in Seed financing to advance innovative solutions for the treatment of Root and Ascending Aortic Diseases.
The funding round was led by a group of experienced MedTech angel investors with strong participation from Cedars-Sinai Intellectual Property Company along with inQB8's existing investors. The funds will support the continued development of the Veritas Transcatheter Valved Aortic Root Conduit (TVARC) through First-in-Human clinical use. The Veritas TVARC is designed to offer a comprehensive, interventional, non-surgical treatment for high-risk Root and Ascending Aortic Diseases, including Dissections, Aneurysms, and other pathologies that specifically involve the aortic root, coronary ostia, and/or the ascending aorta.
The funding round was led by a group of experienced MedTech angel investors with strong participation from Cedars-Sinai Intellectual Property Company along with inQB8's existing investors. The funds will support the continued development of the Veritas Transcatheter Valved Aortic Root Conduit (TVARC) through First-in-Human clinical use. The Veritas TVARC is designed to offer a comprehensive, interventional, non-surgical treatment for high-risk Root and Ascending Aortic Diseases, including Dissections, Aneurysms, and other pathologies that specifically involve the aortic root, coronary ostia, and/or the ascending aorta.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors
